Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. GRFS

Market Cap: $6.39B

GS

Grifols, S.A.

GRFS
NASDAQ (NASDAQ Global Select)USD
Purchase GRFS
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin37.23%
EBITDA Margin21.83%
EBIT Margin17.60%
Pre-tax Margin9.01%
Net Profit Margin6.09%
Earnings Yield6.76%
Valuation Multiples
Price / Book1.21
Price / Sales0.90
Price / Earnings14.66
PEG0.26
Forward PEG0.49
EV / Sales1.98
EV / EBITDA9.07
EV / Operating Cash Flow13.44
EV / Free Cash Flow19.16
Price / Free Cash Flow8.72
Price / Operating Cash Flow6.11
Cash Flow & Capital
Free Cash Flow / Share$1.13
Operating Cash Flow / Share$1.61
Free Cash Flow Yield11.47%
Capex / Revenue4.40%
Capex / Operating Cash Flow29.87%
Capex / Depreciation0.74
Stock Compensation / Revenue0.00%
Dividend Payout Ratio28.31%
Dividend Yield0.84%
Liquidity & Leverage
Current Ratio2.37
Quick Ratio0.81
Cash Ratio0.23
Debt / Assets0.42
Debt / Capital0.61
Debt / Equity1.54
Long-Term Debt / Capital0.56
Debt / Market Cap1.12%
Net Debt / EBITDA4.94
Solvency Ratio0.07
Financial Leverage3.62
Efficiency & Working Capital
Asset Turnover0.37
Fixed Asset Turnover1.83
Inventory Turnover1.33
Receivables Turnover6.24
Payables Turnover4.65
Days Sales Outstanding58.48
Days Inventory Outstanding273.61
Days Payables Outstanding78.43
Operating Cycle332.09
Cash Conversion Cycle253.66
Working Capital Turnover2.39
Returns & Quality
Return on Equity8.43%
Return on Assets2.25%
Return on Invested Capital5.47%
ROCE6.93%
Return on Tangible Assets4.40%
Operating Return on Assets6.16%
Income Quality1.87
Tax Burden0.68
Interest Burden0.51
Balance Sheet & Intrinsic Metrics
Enterprise Value$14.69B
Invested Capital$16.95B
Working Capital$3.07B
Tangible Asset Value$-1.84B
Net Current Asset Value$-6.81B
Graham Number$11.04
Graham Net-Net-$13.14
Book Value / Share$11.73
Tangible Book Value / Share-$2.71
Cash / Share$0.78
Financial Health Scores
Piotroski Score7
Altman Z-Score1.06
Revenue$7.43B
EBIT$1.31B
Market Cap$5.57B
Working Capital$3.07B
Retained Earnings$227M
Total Assets$20.09B
Total Liabilities$12.11B